Work

Nano‐Targeted Kinase Inhibitor Treatment of KRAS Mutant Lung Cancer

Year: 2018

Type: article

Source: The FASEB Journal

DOI: 10.1096/fasebj.2018.32.1_supplement.801.10

Authors: Ramya Sridharan, Janki Shah, Yosef Shamay, Daniel Heller

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Honorable Tina Brozman Foundation, Pershing Square Sohn Cancer Research Alliance

OpenAlex ID: W3175646163

FWCI:

Cites:

Cited by:

Related to: 10